TopoTarget USA's Unit Acquisition

TopoTarget USA raised a round of funding on December 09, 2011. Investors include Apricus Biosciences.

Topotarget USA is an oncology company that is improving quality and prolonging life of cancer patients by offering safe and effective cancer drugs. The company's lead compound belinostat is a Histone …

Articles about TopoTarget USA's Unit Acquisition: